Vermont H0136 mandates health insurance and Medicaid coverage for biomarker testing.

Vermont H0136 requires health insurance and Medicaid coverage for biomarker testing, aiming to optimize clinical care outcomes. Biomarker testing involves analyzing a patient's tissue, blood, or other biospecimen for the presence of a biomarker, including gene mutations and protein expression. The coverage must limit disruptions in care, such as the need for multiple biopsies. The bill also mandates the Agency of Human Services to request approval from the Centers for Medicare and Medicaid Services to amend Vermont’s Medicaid state plan if necessary.

Vermont H0136 mandates health insurance and Medicaid coverage for biomarker testing.

Vermont H0136 requires health insurance and Medicaid coverage for biomarker testing, aiming to optimize clinical care outcomes. Biomarker testing involves analyzing a patient's tissue, blood, or other biospecimen for the presence of a biomarker, including gene mutations and protein expression. The coverage must limit disruptions in care, such as the need for multiple biopsies. The bill also mandates the Agency of Human Services to request approval from the Centers for Medicare and Medicaid Services to amend Vermont’s Medicaid state plan if necessary.